ABILIFY
OTSUKA PHARMACEUTICAL CO LTD
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is ABILIFY discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that ABILIFY 2MG has been permanently discontinued (last updated March 1, 2021). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is ABILIFY not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
AG-ARIPIPRAZOLE
ANGITA PHARMA INC.
NRA-ARIPIPRAZOLE
NORA PHARMA INC
SANDOZ ARIPIPRAZOLE TABLET
SANDOZ CANADA INCORPORATED
Other Products
AURO-ARIPIPRAZOLE
AURO PHARMA INC
PMS-ARIPIPRAZOLE
PHARMASCIENCE INC
SANDOZ ARIPIPRAZOLE
SANDOZ CANADA INCORPORATED
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02322374
Strength
2MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage History
Other Products from OTSUKA PHARMACEUTICAL CO LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
15MG · DIN 02322404
10MG · DIN 02322390
5MG · DIN 02322382
30MG · DIN 02322455
20MG · DIN 02322412
960MG · DIN 02554577
720MG · DIN 02554569
400MG · DIN 02420872
300MG · DIN 02420864
60MG · DIN 02240602
DIN 02437538
DIN 02437503